Schedule 13G ownership disclosure

Edgewise Therapeutics Inc

Security class unavailable · CUSIP: 28036F105

Event date: 2021-07-01

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
4.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-21-091164
Form type
SC 13G
Filer
CITADEL ADVISORS LLC
CIK
CIK 1423053
Filed
Jul 12, 2021
Reporting period
Jul 01, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub